Navigation Links
Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohn's Disease in the European Union
Date:3/7/2013

efore, vedolizumab, by preventing this interaction, has a gut selective effect.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, http://www.takeda.com.

This press release contains forward-looking statements. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and uncertainties include, but are not limited to, (1) the economic circumstances surrounding Takeda's business, including general economic conditions in Japan, the United States and worldwide; (2) competitive pressur
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
2. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
3. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
4. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
5. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
8. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
9. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
10. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
11. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...   Intarcia Therapeutics, Inc. today announced its ... Sessions of the American Diabetes Association taking place June ... the Boston Convention and Exhibition Center. The presentations span ... currently marketed and investigational therapies on patients with type ... late-stage clinical candidate, ITCA 650. , Saturday ...
(Date:6/3/2015)... , June 02, 2015 Research ... addition of the "2015 Strategies in the ... their offering. Highlights of the Report ... the US tumor marker testing market. , ... as well as key economic, regulatory, demographic, social ...
(Date:6/3/2015)... BARBARA, Calif. , June 3, 2015  The ... formal endorsement of a Midwife Kit as a standard ... Kit was developed by Direct Relief in consultation with ... of charge to midwives in developing countries. ... from complications related to their pregnancy or childbirth.  Skilled ...
Breaking Medicine Technology:Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 2Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 3Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 4United States Strategies in the Tumor Marker Testing Market 2015 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 4
(Date:6/3/2015)... Loma Linda University Health and Adventist Health ... Memorial Hospital (SGMH). The SGMH board voted unanimously to ... “Loma Linda University Health has been serving the Pass ... officer, Loma Linda University Medical Center. “We are thrilled ... this community.” , Under the proposed affiliation, Loma ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Johnson ... to pay $7.8 million to resolve a Risperdal lawsuit ... over tactics the company allegedly used to market the ... Circuit Court indicate that the Arkansas Attorney General moved ... of the accord. The Risperdal settlement amounts to just ...
(Date:6/3/2015)... 2015 The National Resident Matching Program ... C. Savoia, M.D., Dean of Medical Education at the University ... Chair on July 1. , “It is an ... Resident Matching Program,” said Dr. Savoia. “NRMP’s goal is ... medical students with training programs, and I welcome the opportunity ...
(Date:6/3/2015)... On the heels of a report predicting ... ( click here to review news coverage about the ... has the talent to become a world-leading center of ... other biological data are collected and analyzed to help scientists ... the elements of a perfect storm for bioinformatics leadership,” said ...
(Date:6/3/2015)... Jersey (PRWEB) June 03, 2015 Horizon Blue ... Diversity MBA Magazine as one of the nation’s top employers ... BCBSNJ No. 6 among its national list of Best Places ... BNCBSNJ as the No. 1 Regional Company. This is ... by Diversity MBA Magazine for its diverse workplace policies and ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2
... Jan. 7 The following is a statement by ... of the State address put forth recommendations on a ... care and financial security of New Yorkers of all ... Family Health Plus Program to 200 percent of the ...
... Whether low levels would work for ER patients with ... -- Going to the world,s most elevated natural laboratory, ... medical rules about the amount of oxygen needed by ... people can tolerate extremely low levels of oxygen, much ...
... known as Emily,s Law, has received Governor Ted Strickland,s ... of Ohio. Named after Emily Jerry, Emily,s Law will ... law, which was originally sponsored by Senator Tim Grendell, ... Association. Emily,s Story , Emily Jerry died at ...
... Provide Support and Convenience CARLSBAD, Calif., Jan. 7 ... a new on-line service for physicians and patients ... products. The new Web site, www.skinmedica.com , ... while offering the convenience of on-line information and ...
... WESTCHESTER, Ill., Jan. 7 BrainLAB, Inc., ... medical treatments,announces a new, customer-focused sales and ... growth and an expanding product,portfolio. , ... and support structures, customers will benefit,from a ...
... AR, AZ, CO, FL, LA, NM and TXBOISE, Idaho, ... its Albertsons Rx-tra Savings prescription discount program ... a 90-day supply of over 500 generic drugs. ... its formulary of over 500 drugs that are already ...
Cached Medicine News:Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:SkinMedica Launches On-Line Service for Physician Partners 2Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
... is the newest addition to the Primus ... the unbeatable combination of speed and accuracy ... or moderate volume testing. Test results in ... technology for the lab or clinic., ,The ...
... HbA1c Testing , Monoclonal antibody method ... , Correlation study shows 99% agreement with ... can count on a CV of ... National Glycohemoglobin Standardization Program (NGSP) certified method, ...
... M-4 is a manual hemostasis analyzer ... clotting assays - PTs, aPTTs, thrombins, ... easy, inexpensive, low-volume testing, this analyzer ... on features, offering time and labor ...
Medicine Products: